SLN

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Silence Therapeutics PLC

NASDAQ | SLN

4.90

USD

$0.00

(

0.00%

)

At Close (As of Sep 18, 2025)

$236.64M

Market Cap

-

P/E Ratio

-1.68

EPS

$20.48

52 Week High

$1.97

52 Week Low

HEALTHCARE

Sector

SLN Chart

Recent Chart
Price Action

SLN Technicals

Tags:

SLN Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $31M
Total Revenue $43M
Cost Of Revenue $12M
Costof Goods And Services Sold $12M
Operating Income -$63M
Selling General And Administrative $27M
Research And Development $68M
Operating Expenses $95M
Investment Income Net -
Net Interest Income $4.5M
Interest Income $4.5M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $593K
Income Before Tax -$44M
Income Tax Expense $845K
Interest And Debt Expense -
Net Income From Continuing Operations -$45M
Comprehensive Income Net Of Tax -
Ebit -$50M
Ebitda -$49M
Net Income -$45M

Revenue & Profitability

Earnings Performance

SLN Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $203M
Total Current Assets $187M
Cash And Cash Equivalents At Carrying Value $121M
Cash And Short Term Investments $121M
Inventory -
Current Net Receivables $27M
Total Non Current Assets $15M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $312K
Intangible Assets Excluding Goodwill $312K
Goodwill $9.4M
Investments -
Long Term Investments -
Short Term Investments $26M
Other Current Assets $13M
Other Non Current Assets -
Total Liabilities $69M
Total Current Liabilities $17M
Current Accounts Payable $3.7M
Deferred Revenue -
Current Debt -
Short Term Debt $117K
Total Non Current Liabilities $52M
Capital Lease Obligations $117K
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $117K
Other Current Liabilities $12M
Other Non Current Liabilities -
Total Shareholder Equity $134M
Treasury Stock -
Retained Earnings -$474M
Common Stock $10M
Common Stock Shares Outstanding $47M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$68M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $593K
Capital Expenditures $211K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$22M
Cashflow From Financing $142M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$36M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $31M
Total Revenue $43M
Cost Of Revenue $12M
Costof Goods And Services Sold $12M
Operating Income -$63M
Selling General And Administrative $27M
Research And Development $68M
Operating Expenses $95M
Investment Income Net -
Net Interest Income $4.5M
Interest Income $4.5M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $593K
Income Before Tax -$44M
Income Tax Expense $845K
Interest And Debt Expense -
Net Income From Continuing Operations -$45M
Comprehensive Income Net Of Tax -
Ebit -$50M
Ebitda -$49M
Net Income -$45M

SLN News

SLN Profile

Silence Therapeutics PLC Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Silence Therapeutics PLC is a London-based biotechnology company specializing in the development of innovative ribonucleic acid (RNA) therapies aimed at addressing unmet medical needs in hematology, cardiovascular diseases, and various rare and metabolic disorders. By leveraging its proprietary RNAi technology platform, Silence is positioned to advance transformative therapeutics that target specific disease mechanisms, offering potentially groundbreaking treatments for patients. With a robust pipeline of product candidates, the company is committed to driving innovation in the biopharmaceutical landscape and enhancing patient outcomes through targeted RNA-based solutions.

INTC
+28.93%
$32.10
DVLT
+16.60%
$0.39
CGBS
-39.47%
$0.03
SNAP
+3.23%
$7.99
AERT
+58.84%
$0.90
ADAP
+27.84%
$0.10
GPUS
+28.56%
$0.52
APVO
+37.48%
$1.93
BITF
+11.31%
$3.39
ATCH
-3.39%
$1.56
NEHC
-4.00%
$0.45
NVDA
+2.92%
$175.27
TPIC
-45.91%
$0.12
PLUG
+4.49%
$2.08
AXDX
-61.36%
$0.03
CDLX
+64.40%
$2.35
ETNB
+85.21%
$14.96
LASE
+33.52%
$3.73
RGTI
+16.16%
$25.54
LYT
-16.77%
$0.09
GRAB
+3.34%
$6.30
KDLY
-4.66%
$1.43
AMD
-3.10%
$154.22
CJET
+2.15%
$0.09
MULN
-6.96%
$0.06
VHAI
0.00%
$0.00
RMBL
+60.50%
$3.21
TSLA
-0.25%
$424.76
AAL
+0.76%
$12.57
ADD
-25.47%
$0.05
BMNR
+6.16%
$60.59
SRM
+53.27%
$10.30
NIO
-0.06%
$7.44
BINI
-15.47%
$0.05
SOUN
+1.71%
$15.37
PLTR
+3.67%
$174.52
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
QBTS
+2.75%
$23.16
WLGS
-5.57%
$0.04
NFE
+14.87%
$2.48
RAYA
-4.69%
$0.04
RR
+10.73%
$4.40
ETWO
0.00%
$3.30
CLSK
+13.25%
$12.95
MARA
+6.63%
$18.48
QS
+11.20%
$11.41
AFMD
-34.94%
$0.18
PBM
+32.25%
$4.92
NVNI
+22.95%
$0.98
SMCI
-0.02%
$44.90
QUBT
+3.67%
$18.36
BEEM
+18.47%
$2.99
BURU
+0.14%
$0.13
IXHL
+1.25%
$0.53
IONQ
+7.02%
$70.04
DNN
-1.18%
$2.50
F
+0.08%
$11.67
AQB
+17.98%
$1.34
SOFI
+1.30%
$27.49
GRYP
-10.38%
$1.38
MODV
-25.22%
$0.43
CDE
-1.65%
$16.00
BCDA
-23.12%
$1.18
BBD
-1.20%
$3.27
ONDS
+2.66%
$6.26
BTG
-0.92%
$4.29
HOOD
+3.04%
$122.24
LDI
-11.73%
$4.02
CIFR
-4.02%
$11.88
QSI
+24.20%
$1.56
AAPL
-0.26%
$238.34
SBET
+6.69%
$18.26
LAWR
+37.17%
$2.77
IONZ
-10.18%
$4.31
RCAT
-7.41%
$10.43
UEC
-5.59%
$11.55
NOK
+1.06%
$4.75
AMZN
+0.34%
$232.42
ORIS
+9.67%
$0.15
OPI
-34.61%
$0.37
ZAPP
-46.30%
$0.15
ADGM
-3.68%
$1.57
AIRE
-4.00%
$1.19
NVO
+6.30%
$61.87
NAKA
-1.04%
$1.41
JOBY
+2.66%
$14.53
CAN
+1.86%
$0.82
BTBT
+4.45%
$3.16
YAAS
-6.49%
$0.06
TLRY
+2.52%
$1.22
REPL
-41.94%
$3.31
ORBS
+22.92%
$13.35
ORCL
-0.48%
$299.95
ABEV
-0.84%
$2.34
BABA
-2.29%
$162.36
RZLV
-1.64%
$6.99
APLD
+2.34%
$20.29
NVTS
+3.83%
$6.70
BTE
-1.89%
$2.50
INTC
+28.93%
$32.10
DVLT
+16.60%
$0.39
CGBS
-39.47%
$0.03
SNAP
+3.23%
$7.99
AERT
+58.84%
$0.90
ADAP
+27.84%
$0.10
GPUS
+28.56%
$0.52
APVO
+37.48%
$1.93
BITF
+11.31%
$3.39
ATCH
-3.39%
$1.56
NEHC
-4.00%
$0.45
NVDA
+2.92%
$175.27
TPIC
-45.91%
$0.12
PLUG
+4.49%
$2.08
AXDX
-61.36%
$0.03
CDLX
+64.40%
$2.35
ETNB
+85.21%
$14.96
LASE
+33.52%
$3.73
RGTI
+16.16%
$25.54
LYT
-16.77%
$0.09
GRAB
+3.34%
$6.30
KDLY
-4.66%
$1.43
AMD
-3.10%
$154.22
CJET
+2.15%
$0.09
MULN
-6.96%
$0.06
VHAI
0.00%
$0.00
RMBL
+60.50%
$3.21
TSLA
-0.25%
$424.76
AAL
+0.76%
$12.57
ADD
-25.47%
$0.05
BMNR
+6.16%
$60.59
SRM
+53.27%
$10.30
NIO
-0.06%
$7.44
BINI
-15.47%
$0.05
SOUN
+1.71%
$15.37
PLTR
+3.67%
$174.52
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
QBTS
+2.75%
$23.16
WLGS
-5.57%
$0.04
NFE
+14.87%
$2.48
RAYA
-4.69%
$0.04
RR
+10.73%
$4.40
ETWO
0.00%
$3.30
CLSK
+13.25%
$12.95
MARA
+6.63%
$18.48
QS
+11.20%
$11.41
AFMD
-34.94%
$0.18
PBM
+32.25%
$4.92
NVNI
+22.95%
$0.98
SMCI
-0.02%
$44.90
QUBT
+3.67%
$18.36
BEEM
+18.47%
$2.99
BURU
+0.14%
$0.13
IXHL
+1.25%
$0.53
IONQ
+7.02%
$70.04
DNN
-1.18%
$2.50
F
+0.08%
$11.67
AQB
+17.98%
$1.34
SOFI
+1.30%
$27.49
GRYP
-10.38%
$1.38
MODV
-25.22%
$0.43
CDE
-1.65%
$16.00
BCDA
-23.12%
$1.18
BBD
-1.20%
$3.27
ONDS
+2.66%
$6.26
BTG
-0.92%
$4.29
HOOD
+3.04%
$122.24
LDI
-11.73%
$4.02
CIFR
-4.02%
$11.88
QSI
+24.20%
$1.56
AAPL
-0.26%
$238.34
SBET
+6.69%
$18.26
LAWR
+37.17%
$2.77
IONZ
-10.18%
$4.31
RCAT
-7.41%
$10.43
UEC
-5.59%
$11.55
NOK
+1.06%
$4.75
AMZN
+0.34%
$232.42
ORIS
+9.67%
$0.15
OPI
-34.61%
$0.37
ZAPP
-46.30%
$0.15
ADGM
-3.68%
$1.57
AIRE
-4.00%
$1.19
NVO
+6.30%
$61.87
NAKA
-1.04%
$1.41
JOBY
+2.66%
$14.53
CAN
+1.86%
$0.82
BTBT
+4.45%
$3.16
YAAS
-6.49%
$0.06
TLRY
+2.52%
$1.22
REPL
-41.94%
$3.31
ORBS
+22.92%
$13.35
ORCL
-0.48%
$299.95
ABEV
-0.84%
$2.34
BABA
-2.29%
$162.36
RZLV
-1.64%
$6.99
APLD
+2.34%
$20.29
NVTS
+3.83%
$6.70
BTE
-1.89%
$2.50
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.